PROTECTION OF T-LYMPHOCYTES VIA PD-1 RECEPTOR: NEW MOLECULAR MECHANISM OF CANCER IMMUNOTHERAPY
After briefl y reviewing major forms of cell death and discovery of programmed (cell) death 1 (PD-1) protein and its ligands (PD-L1 and PD-L2), this overview is focused on how PD-1 and PD-1 ligands are involved in a new form of in immunosuppression that represents a new approach to cancer therapy. N...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shevchenko Scientific Society
2019-12-01
|
| Series: | Праці Наукового товариства імені Шевченка. Медичні науки |
| Subjects: | |
| Online Access: | https://mspsss.org.ua/index.php/journal/article/view/209 |